Skip to main content
Premium Trial:

Request an Annual Quote

Siemens, Sysmex Sign Distribution Deal

NEW YORK (GenomeWeb News) – Siemens Healthcare has agreed to a five-year supply, distribution, sales, and service contract with Japanese firm Sysmex, Siemens said today.

The global agreement will cover distribution of a variety of diagnostic tests and coagulation instruments to test and monitor patients using blood thinning medications, Siemens said. The agreement also includes access to automated platelet function testing.

The firms also intend to continue joint product development efforts related to coagulation technology.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.